ストックスクリーナーアプリを入手
4.88
0.61%
-0.03
プレマーケット:
4.83
-0.05
-1.02%
前日終値:
$4.91
開ける：
$4.85
24時間の取引高:
28.70M
Relative Volume:
1.14
時価総額：
$2.09B
収益：
$64.60M
当期純損益:
$-377.75M
株価収益率:
-3.1484
EPS:
-1.55
ネットキャッシュフロー:
$-335.64M
1週間 パフォーマンス:
+1.46%
1か月 パフォーマンス:
+3.83%
6か月 パフォーマンス:
-7.75%
1年 パフォーマンス:
-25.95%
1日の値動き範囲:
$4.73
$4.88
1週間の範囲:
$4.57
$5.17
52週間の値動き範囲:
$3.79
$12.36
Recursion Pharmaceuticals Inc Stock (RXRX) Company Profile
名前
Recursion Pharmaceuticals Inc
セクター
電話
(385) 269-0203
住所
41S RIO GRANDE STREET, SALT LAKE CITY
RXRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RXRX
Recursion Pharmaceuticals Inc
|
4.88 | 2.14B | 64.60M | -377.75M | -335.64M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Recursion Pharmaceuticals Inc Stock (RXRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-03 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-05-22 | 開始されました | Morgan Stanley | Equal-Weight |
| 2023-03-16 | 開始されました | Needham | Buy |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2022-04-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-03-04 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-09-21 | 開始されました | Berenberg | Buy |
| 2021-05-11 | 開始されました | BofA Securities | Buy |
| 2021-05-11 | 開始されました | Goldman | Neutral |
| 2021-05-11 | 開始されました | JP Morgan | Neutral |
| 2021-05-11 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2021-05-11 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Recursion Pharmaceuticals Inc (RXRX) 最新ニュース
Will Recursion Pharmaceuticals Inc. stock recover faster than marketTrend Reversal & AI Enhanced Execution Alerts - newser.com
Needham Reiterates a Buy on Recursion Pharmaceuticals (RXRX) - MSN
How to recover losses in Recursion Pharmaceuticals Inc. stockStop Loss & Fast Momentum Entry Tips - newser.com
Published on: 2025-09-30 19:47:45 - newser.com
Jim Cramer on Recursion: “I Need to See a Proof of Concept Here” - MSN
Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years - AOL.com
Smart tools for monitoring Recursion Pharmaceuticals Inc.’s price actionWeekly Profit Analysis & AI Enhanced Trading Alerts - newser.com
Recursion Pharmaceuticals’ Recent Moves: What’s Next? - timothysykes.com
Recursion Pharmaceuticals’ Unexpected Surge - StocksToTrade
Recursion’s New Moves: Market Shake-Up? - timothysykes.com
Can Recursion Pharmaceuticals Inc. recover in the next quarter - newser.com
Should you wait for a breakout in Recursion Pharmaceuticals Inc.Portfolio Update Report & Low Risk Investment Opportunities - newser.com
Published on: 2025-09-29 08:38:45 - newser.com
Nvidia Has Invested in These 6 Companies. Should You Follow Suit? - The Motley Fool
Custom strategy builders for tracking Recursion Pharmaceuticals Inc.Rate Hike & Long-Term Safe Investment Ideas - newser.com
Is Recursion Pharmaceuticals Inc. still worth holding after the dip2025 Analyst Calls & Capital Protection Trading Alerts - newser.com
Top Biotech Stocks To Watch TodaySeptember 25th - MarketBeat
Where Will Recursion Pharmaceuticals Be in 5 Years? - sharewise.com
What drives Recursion Pharmaceuticals Inc stock pricePrice-to-Book Ratio Updates & Don’t Miss These Undervalued Stocks - earlytimes.in
The Biotech Stock That's Too Risky for Most Investors - MSN
Is Recursion Pharmaceuticals Inc. forming a bottoming basePortfolio Performance Summary & Consistent Growth Equity Picks - newser.com
Does Recursion Stock Present an Opportunity After a 32% Drop in 2024? - simplywall.st
Best Biotech Stocks To Follow NowSeptember 27th - MarketBeat
RXRX Stock Down 17% as Q1 Earnings & Revenues Miss Estimates - MSN
Does Short Squeeze Attention and AI Advances Alter the Bull Case for Recursion Pharmaceuticals (RXRX)? - Yahoo Finance
Recursion Pharmaceuticals Inc. (RXRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Recursion Pharma CEO Gibson sells $476k in shares By Investing.com - Investing.com Canada
Recursion Pharma CEO Gibson sells $476k in shares - Investing.com
Prediction: 2 Stocks That Will Be Worth More Than BigBear.ai 5 Years From Now - The Globe and Mail
RXRX Stock: Insider’s Sale Spurs Ripple Effect - timothysykes.com
Trend analysis for Recursion Pharmaceuticals Inc. this weekMarket Growth Summary & Fast Gain Swing Trade Alerts - newser.com
November 7th Options Now Available For Recursion Pharmaceuticals (RXRX) - Nasdaq
Looking for the Next Big Pop? Here’s Why Recursion Pharmaceuticals (RXRX) Could Do a Dead-Cat Bounce - Yahoo Finance
Recursion Pharmaceuticals, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
Why Recursion Pharmaceuticals, Inc. (RXRX) Went Down On Monday? - MSN
Recursion Pharmaceuticals (RXRX): Evaluating Valuation Following Milestone Payment and New AI/Pipeline Developments - simplywall.st
Nvidia-Backed Recursion Pharma Soars After-Hours As FDA Eyes AI Over Animal Testing For Drugs: Retail Traders Elated - MSN
Recursion Pharmaceuticals Surge: Is It Justified? - StocksToTrade
Why is Recursion Pharmaceuticals on the Rise? - timothysykes.com
First Week of November 21st Options Trading For Recursion Pharmaceuticals - Nasdaq
Recursion Pharmaceuticals (RXRX) Laps the Stock Market: Here's Why - sharewise.com
Milestone Payment and AI Initiatives Could Be a Game Changer for Recursion Pharmaceuticals (RXRX) - Sahm
Recursion Pharmaceuticals, Inc. (RXRX) Secures $12.5M Milestone From Rallybio as REV102 Advances - MSN
Recursion Pharmaceuticals Inc (RXRX) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):